Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-25-063792

EVP and Chief Medical Officer sold 762 shares at an average $37.93 ($28,901)

From the SEC's structured data for this filing

Trades in this filing

Crombez Eric · EVP and Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-21 Sale : show line 1 in the form −242 $35.11 $8,497 71,680 D
2025-05-05 Sale : show line 2 in the form −520 $39.24 $20,405 71,530 D
Open-market sales · 762 sh · avg $37.93 · $28,901
Loading xslF345X05/ownership.xml…